Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Monica Bessler

Showing results (71-80 of 85) with videos related to

Pageof 9
Sort By:
Blood|July 30, 2005
Diagnosis and management of paroxysmal nocturnal hemoglobinuriaCharles Parker, Mitsuhiro Omine, Stephen Richards, et al.
BMC Blood Disorders|June 24, 2004
A mutation in a functional Sp1 binding site of the telomerase RNA gene (hTERC) promoter in a patient with Paroxysmal Nocturnal HaemoglobinuriaW Nicol Keith, Tom Vulliamy, Jiangqin Zhao, et al.
British Journal of Haematology|March 17, 2010
Effect of eculizumab on haemolysis-associated nitric oxide depletion, dyspnoea, and measures of pulmonary hypertension in patients with paroxysmal nocturnal haemoglobinuriaAnita Hill, Russell P Rother, Xunde Wang, et al.
Haematologica|February 4, 2014
Baseline characteristics and disease burden in patients in the International Paroxysmal Nocturnal Hemoglobinuria RegistryHubert Schrezenmeier, Petra Muus, Gérard Socié, et al.
Cancer Genetics|December 26, 2015
Clonal evolution and clinical significance of copy number neutral loss of heterozygosity of chromosome arm 6p in acquired aplastic anemiaMarisol Betensky, Daria Babushok, Jacquelyn J Roth, et al.
Blood|June 8, 2013
Ribosomal and hematopoietic defects in induced pluripotent stem cells derived from Diamond Blackfan anemia patientsLoïc Garçon, Jingping Ge, Shwetha H Manjunath, et al.
Blood|October 22, 2008
TERC and TERT gene mutations in patients with bone marrow failure and the significance of telomere length measurementsHong-Yan Du, Elena Pumbo, Jennifer Ivanovich, et al.
Blood|August 19, 2007
Effect of the complement inhibitor eculizumab on thromboembolism in patients with paroxysmal nocturnal hemoglobinuriaPeter Hillmen, Petra Muus, Ulrich Dührsen, et al.
Blood|December 7, 2007
Multicenter phase 3 study of the complement inhibitor eculizumab for the treatment of patients with paroxysmal nocturnal hemoglobinuriaRobert A Brodsky, Neal S Young, Elisabetta Antonioli, et al.
Pediatric Blood & Cancer|November 29, 2013
Diagnosis and treatment of pediatric acquired aplastic anemia (AAA): an initial survey of the North American Pediatric Aplastic Anemia Consortium (NAPAAC)David A Williams, Carolyn Bennett, Alison Bertuch, et al.
Pageof 9

Showing results (71-80 of 85) with videos related to

Sort By:
Pageof 9
Blood|July 30, 2005
Diagnosis and management of paroxysmal nocturnal hemoglobinuriaCharles Parker, Mitsuhiro Omine, Stephen Richards, et al.
BMC Blood Disorders|June 24, 2004
A mutation in a functional Sp1 binding site of the telomerase RNA gene (hTERC) promoter in a patient with Paroxysmal Nocturnal HaemoglobinuriaW Nicol Keith, Tom Vulliamy, Jiangqin Zhao, et al.
British Journal of Haematology|March 17, 2010
Effect of eculizumab on haemolysis-associated nitric oxide depletion, dyspnoea, and measures of pulmonary hypertension in patients with paroxysmal nocturnal haemoglobinuriaAnita Hill, Russell P Rother, Xunde Wang, et al.
Haematologica|February 4, 2014
Baseline characteristics and disease burden in patients in the International Paroxysmal Nocturnal Hemoglobinuria RegistryHubert Schrezenmeier, Petra Muus, Gérard Socié, et al.
Cancer Genetics|December 26, 2015
Clonal evolution and clinical significance of copy number neutral loss of heterozygosity of chromosome arm 6p in acquired aplastic anemiaMarisol Betensky, Daria Babushok, Jacquelyn J Roth, et al.
Blood|June 8, 2013
Ribosomal and hematopoietic defects in induced pluripotent stem cells derived from Diamond Blackfan anemia patientsLoïc Garçon, Jingping Ge, Shwetha H Manjunath, et al.
Blood|October 22, 2008
TERC and TERT gene mutations in patients with bone marrow failure and the significance of telomere length measurementsHong-Yan Du, Elena Pumbo, Jennifer Ivanovich, et al.
Blood|August 19, 2007
Effect of the complement inhibitor eculizumab on thromboembolism in patients with paroxysmal nocturnal hemoglobinuriaPeter Hillmen, Petra Muus, Ulrich Dührsen, et al.
Blood|December 7, 2007
Multicenter phase 3 study of the complement inhibitor eculizumab for the treatment of patients with paroxysmal nocturnal hemoglobinuriaRobert A Brodsky, Neal S Young, Elisabetta Antonioli, et al.
Pediatric Blood & Cancer|November 29, 2013
Diagnosis and treatment of pediatric acquired aplastic anemia (AAA): an initial survey of the North American Pediatric Aplastic Anemia Consortium (NAPAAC)David A Williams, Carolyn Bennett, Alison Bertuch, et al.
Pageof 9